{"id":"W195310058","doi":"","title":"Filibuvir, a non-nucleoside NS5B polymerase inhibitor for the potential oral treatment of chronic HCV infection.","year":2010,"lang":"en","type":"article","venue":"PubMed","topic":"Hepatitis C virus research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Ribavirin; Medicine; Hepatitis C virus; NS5B; Pharmacology; Nitazoxanide; Dosing; Placebo; Internal medicine; Sofosbuvir; Adverse effect; Virology; Immunology; Gastroenterology; Hepacivirus; Virus; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003481874,0.0005683239,0.0003589963,0.0004885729,0.0002779634,0.0004336995,0.000273064,0.000545134,0.005469695],"category_scores_gemma":[0.0001909639,0.0001143531,0.0004081425,0.0002447468,0.0002184136,0.0002458636,0.0002522507,0.00118534,0.001595033],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004448915,"about_ca_system_score_gemma":0.0003748324,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001211993,"about_ca_topic_score_gemma":0.002345246,"domain_scores_codex":[0.9998523,0.00002702201,0.000006326296,0.00002145981,0.00006419309,0.00002862128],"domain_scores_gemma":[0.9999313,0.0000128259,0.00001805316,0.000003806502,0.0000101323,0.00002385134],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001973944,0.001195704,0.001971967,0.001269484,0.00009219661,0.00052577,0.00004717626,0.0002844411,0.06036751,0.001643083,0.02913647,0.9014922],"study_design_scores_gemma":[0.007328298,0.01685829,0.02967382,0.0005379361,0.0004759907,0.01462462,0.0001105332,0.003462255,0.1196934,0.001855423,0.8052577,0.0001217936],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.265714,0.5434793,0.02390769,0.008075803,0.00300387,0.001788876,0.006288755,0.00326168,0.1444799],"genre_scores_gemma":[0.7890961,0.1285989,0.01445419,0.003934562,0.001146141,0.0005708652,0.007315986,0.0001099607,0.05477331],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.005469695,"threshold_uncertainty_score":0.01829803,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02564961904086843,"score_gpt":0.2958526600535313,"score_spread":0.2702030410126629,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}